Recent advances in the pharmacokinetics of local anaesthetics. Long-acting amide enantiomers and continuous infusions

Clinical Pharmacokinetics

Volumn 36, Issue 1, 1999, Pages 67-83

  Thomas, Jane M ^a   Schug, Stephan A ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; LOCAL ANESTHETIC AGENT; MEPIVACAINE; PLASMA PROTEIN; ROPIVACAINE;

ANALGESIA; BRACHIAL PLEXUS ANESTHESIA; BRAIN; CARDIOTOXICITY; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG SOLUBILITY; DRUG TRANSFORMATION; ENANTIOMER; EPIDURAL DRUG ADMINISTRATION; HEART; HUMAN; INTERCOSTAL MUSCLE; INTRAVENOUS DRUG ADMINISTRATION; NEUROTOXICITY; NONHUMAN; POSTOPERATIVE ANALGESIA; PREGNANCY; PRIORITY JOURNAL; RACEMIC MIXTURE; REVIEW; STEREOCHEMISTRY;

AMIDES; ANESTHETICS, LOCAL; ANIMALS; BLOOD PROTEINS; BUPIVACAINE; FEMALE; HUMANS; PREGNANCY; PROTEIN BINDING; STEREOISOMERISM; SURGICAL PROCEDURES, OPERATIVE;

EID: 0032901485     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199936010-00005     Document Type: Review

References (50)

1. 1. Denson DD, Behbehani MM, Gregg RV. Enantiomer-specific effects of an intravenously administered arrhythmogenic dose of bupivacaine on neurons of the nucleus tractus solitarius and the cardiovascular system in the anesthetized rat. Reg Anesth 1992; 17(6): 311-6
2. 2. Nancarrow C, Rutten AJ, Runciman WB, et al. Myocardial and cerebral drug concentrations and the mechanisms of death after fatal intravenous doses of lidocaine, bupivacaine, and ropivacaine in the sheep. Anesth Analg 1989; 69 (3): 276-83
3. 3. Feldman HS, Arthur GR, Covino BG. Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog. Anesth Analg 1989; 69 (6): 794-801
4. 4. Scott DB, Lee A, Fagan D, et al. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989; 69 (5): 563-9
5. 5. Zaric D, Nydahl PA, Philipson L, et al. The effect of continuous lumbar epidural infusion of ropivacaine (0.1%, 0.2%, and 0.3% ) and 0.25% bupivacaine on sensory and motor block in volunteers: a double-blind study. Reg Anesth 1996; 21 (1): 14-25
6. 6. Tucker GT. Pharmacokinetics of local anaesthetics. Br J Anaesth 1986; 58 (7): 717-31
7. 7. Santos AC, Arthur GR, Lehning EJ, et al. Comparative pharmacokinetics of ropivacaine and bupivacaine in nonpregnant and pregnant ewes. Anesth Analg 1997; 85 (1): 87-93
8. 8. Arthur GR, Feldman HS, Covino BG. Comparative pharmacokinetics of bupivacaine and ropivacaine, a new amide local anesthetic. Anesth Analg 1988; 67 (11): 1053-8
9. 9. Katz JA, Sehlhorst CS, Thompson GA, et al. Pharmacokinetics of intravenous and epidural ropivacaine in the rhesus monkey. Biopharm Drug Dispos 1993; 14 (7): 579-88
10. 10. Thompson GA, Turner PA, Bridenbaugh PO, et al. The influence of diazepam on the pharmacokinetics of intravenous and epidural bupivacaine in the rhesus monkey. Anesth Analg 1986; 65 (2): 151-5
11. 11. Rutten AJ, Mather LE, Plummer JL, et al. Postoperative course of plasma protein binding of lignocaine, ropivacaine and bupivacaine in sheep. J Pharm Pharmacol 1992; 44: 355-8
12. 12. Rutten AJ, Mather LE, Nancarrow C, et al. Cardiovascular effects and regional clearances of intravenous ropivacaine in sheep. Anesth Analg 1990; 70 (6): 577-82
13. 13. Santos AC, Pedersen H, Sullusto JA, et al. Pharmacokinetics of ropivacaine in nonpregnant and pregnant ewes. Anesth Analg 1990; 70 (3): 262-6
14. 14. Lee A, Fagan D, Lamont M, et al. Disposition kinetics of ropivacaine in humans. Anesth Analg 1989; 69 (6): 736-8
15. 15. Emanuelsson BM, Persson J, Sandin S, et al. Intraindividual and interindividual variability in the disposition of the local anesthetic ropivacaine in healthy subjects. Ther Drug Monit 1997; 19 (2): 126-31
16. 16. Halldin MM, Bredberg E, Angelin B, et al. Metabolism and excretion of ropivacaine in humans. Drug Metab Dispos 1996; 24 (9): 962-8
17. 17. Ekstrom G, Gunnarsson UB. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes. Drug Metab Dispos 1996; 24 (9): 955-61
18. 18. Katz JA, Bridenbaugh PO, Knarr DC, et al. Pharmacodynamics and pharmacokinetics of epidural ropivacaine in humans. Anesth Analg 1990; 70 (1): 16-21
19. 19. Morrison LM, Emanuelsson BM, McClure JH, et al. Efficacy and kinetics of extradural ropivacaine: comparison with bupivacaine. Br J Anaesth 1994; 72 (2): 164-9
20. 20. Emanuelsson BM, Zaric D, Nydahl PA, et al. Pharmacokinetics of ropivacaine and bupivacaine during 21 hours of continuous epidural infusion in healthy male volunteers. Anesth Analg 1995; 81 (6): 1163-8
21. 21. Erichsen CJ, Sjovall J, Keblet H, et al. Pharmacokinetics and analgesic effect of ropivacaine during continuous epidural infusion for postoperative pain relief. Anesthesiology 1996; 84 (4): 834-42
22. 22. Burm AGL, Vermeule NPE, Van Kleef JW, et al. Pharmacokinetics of lignocaine and bupivacaine in surgical patients following epidural administration: simultaneous investigation of absorption and disposition kinetics using stable isotopes. Clin Pharmacokinet 1987; 13: 191-203
23. 23. Burm AGL. Clinical pharmacokinetics of epidural and spinal anesthesia. Clin Pharmacokinet 1989; 16: 283-311
24. 24. Kopacz DJ, Emanuelsson BM, Thompson GE, et al. Pharmacokinetics of ropivacaine and bupivacaine for bilateral intercostal blockade in healthy male volunteers. Anesthesiology 1994; 81 (5): 1139-48
25. 25. Hickey R, Blanchard J, Hoffman J, et al. Plasma concentrations of ropivacaine given with or without epinephrine for brachial plexus block. Can J Anaesth 1990; 37 (8): 878-82
26. 26. Mather LE. Disposition of mepivacaine and bupivacaine enantiomers in sheep. Br J Anaesth 1991 ; 67 (3): 239-46
27. 27. Rutten AJ, Mather LE, McLean CF. Cardiovascular effects and regional clearances of i.v. bupivacaine in sheep: enantiomeric analysis. Br J Anaesth 1991; 67 (3): 247-56
28. 28. Gristwood R, Bardsley H, Baker H, et al. Reduced cardiotoxicity of levobupivacaine compared with racemic bupivacaine (Marcaine): new clinical evidence. Expert Opin Invest Drugs 1994; 3 (11); 1209-12
29. 29. Mazoit JX, Boico O, Samii K. Myocardial uptake of bupivacaine: II. Pharmacokinetics and pharmacodynamics of bupivacaine enantiomers in the isolated perfused rabbit heart. Anesth Analg 1993; 77 (3): 477-82
30. 30. Rutten AJ, Mather LE, McLean CF, et al. Tissue distribution of bupivacaine enantiomers in sheep. Chirality 1993; 5 (7): 485-91
31. 31. Mather LE, Rutten AJ, Plummer JL. Pharmacokinetics of bupivacaine enantiomers in sheep: influence of dosage regimen and study design. J Pharmacokinet Biopharm 1994; 22 (6): 481-98
32. 32. Mazoit JX, Lin Sen C, Samii K. Binding of bupivacaine to human serum proteins, isolated albumin and isolated alpha-1 -acid glycoprotein: differences between the two enantiomers are partly due to cooperativity. J Pharmacol Exper Ther 1996; 276 (1): 109-15
33. 33. Burm AG, van der Meer AD, van Kleef JW, et al. Pharmacokinetics of the enantiomers of bupivacaine following intravenous administration of the racemate. Br J Clin Pharmacol 1994; 38 (2): 125-9
34. 34. Berrisford RG, Sabanathan S, Mearns AJ, et al. Plasma concentrations of bupivacaine and its enantiomers during continuous extrapleural intercostal nerve block. Br J Anaesth 1993; 70 (2): 201-4
35. 35. Mather LE, McCall P, McNicol PL. Bupivacaine enantiomer pharmacokinetics after intercostal neural blockade in liver transplantation patients. Anesth Analg 1995; 80 (2): 328-35
36. 36. Blake DW, Bjorksten A, Dawson P, et al. Pharmacokinetics of bupivacaine enantiomers during interpleural infusion. Anaesth Intens Care 1994; 22 (5): 522-8
37. 37. De Leon-Casasola OA, Lema MJ. Postoperative epidural opioid analgesia: what are the choices? Anesth Analg 1996; 83: 867-75
38. 38. Mazoit JX, Lambert C, Bordeaux A, et al. Pharmacokinetics of bupivacaine after short and prolonged infusions in conscious dogs. Anesth Analg 1988; 67: 961-6
39. 39. Denson DD, Thompson GA, Raj PP, et al. Continuous perineural infusions of bupivacaine for prolonged analgesia: pharmacokinetic considerations. Int J Clin Pharmacol Ther Toxicol 1983; 21 (12): 591-7
40. 40. Richter O, Klein K, Abel J, et al. The kinetics of bupivacaine (Carbostesin) plasma concentrations during epidural anesthesia following intraoperative bolus injection and subsequent continuous infusion. Int J Clin Pharmacol Ther Toxicol 1984; 22: 611-7
41. 41. Raj PP, Knarr DC, Vigdorth E, et al. Comparison of continuous epidural infusion of a local anesthetic and administration of systemic narcotics in the management of pain after total knee replacement surgery. Anesth Analg 1987; 66: 401-6
42. 42. Perkins FM. Pharmacokinetics of bupivacaine following prolonged administration [abstract]. Anesthesiology 1989; 71: 3A
43. 43. Bruguerolle B, Dupont M, Lebre P, et al. Bupivacaine chronokinetics in man after a peridural constant rate infusion. Annu Rev Chronopharmacol 1988; 5: 223-6
44. 44. Schweitzer SA, Morgan DJ. Plasma bupivacaine concentrations during postoperative continuous epidural analgesia. Anaesth Intens Care 1987; 15: 425-30
45. 45. Wulf H, Winckler K, Maier C, et al. Pharmacokinetics and protein binding of bupivacaine in postoperative epidural analgesia. Acta Anaesthesiol Scand 1988; 32: 530-4
46. 46. Kastrissios H, Triggs EJ, Mogg GA, et al. The disposition of bupivacaine following a 72h interpleural infusion in cholecystectomy patients. Br J Clin Pharmacol 1991; 32: 251-4
47. 47. Schug SA, Payne JA, Baker P, et al. Non-stationary pharmacokinetics of bupivacaine during continuous interpleural infusion. Acute Pain 1997; 1 (1): 15-20
48. 48. van Kleef JW, Logeman EA, Burm AG, et al. Continuous interpleural infusion of bupivacaine for postoperative analgesia after surgery with flank incisions: a double-blind comparison of 0.25% and 0.5% solutions. Anesth Analg 1992; 75: 268-74
49. 49. Tuominen M, Pitkanen M, Rosenberg PH. Postoperative pain relief and bupivacaine plasma levels during continuous interscalene brachial plexus block. Acta Anaesthesiol Scand 1987; 31: 276-8
50. 50. Rosenberg PH, Pere P, Hekali R, et al. Plasma concentrations of bupivacaine and two of its metabolites during continuous interscalene brachial plexus block. Br J Anaesth 1991; 66: 25-30